Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal - A Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06152055

Enrollment

Registered

2023-11-30

Start date

2022-05-01

Completion date

2023-04-30

Last updated

2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

Head and Neck Cancer, Radiotherapy, Chemotherapy

Brief summary

This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.

Detailed description

This is a retrospective study to know the prevalence of Head and Neck Cancer at the department of ENT- Head and Neck Surgery of Shree Birendra Hospital ,a tertiary health care centre of Nepal .Head and neck cancers are malignant neoplasms that develops in oral cavity, nasal cavities, paranasal sinuses,nasopharynx, oropharynx, hypopharynx, ear, scalp, salivary gland and neck,Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023. Data considered of demographic details of age, sex, diagnosis, subsite specific Head and Neck Cancers, treatment modality and histopathology. The data was analyzed using Stastical Package for Social Sciences (SPSS) version 22. Pearson's chi-square test was applied and p value \<0.05 was considered statistically significant.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to 84 Years

Healthy volunteers

Inclusion criteria

* All histologically proven cases of head and neck region.

Exclusion criteria

* Patient's record with incomplete data.

Design outcomes

Primary

Measure	Time frame	Description
Age - wise Distribution of Head and Neck Cancers (HNCs)	1 year	Age - wise Distribution of Head and Neck Cancer
: Distribution of HNCs according to subsite	1 year	Distribution of Head and Neck Cancers according to the subsite
Histopathology of HNCs	1 year	Histopathology of Head and Neck Cancer
Tumor, Nodes, Metastasis (TNM) staging of HNC	1 year	Staging at presentation of Head and Neck Cancer
Treatment provided to HNC patients	1 year	Treatment Modalities of Head and Neck Cancer

Countries

Nepal

Outcome results